Know Cancer

or
forgot password

A Non-interventional Survey on the Epidermal Growth Factor Receptor (EGFR) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology


N/A
18 Years
N/A
Open (Enrolling)
Both
Non-Small Cell Lung Cancer

Thank you

Trial Information

A Non-interventional Survey on the Epidermal Growth Factor Receptor (EGFR) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology


Inclusion Criteria:



- Histological diagnosed as adenocarcinoma type of non-small cell lung cancer

- Have completed lung cancer operation

- The tumour EGFR gene mutation status test was performed as regular medical practice

Exclusion Criteria:

- Patients who disagree to participate this study

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

type and prevalence of EGFR mutation

Outcome Time Frame:

up to 3 months

Safety Issue:

No

Principal Investigator

Karen Atkin

Investigator Role:

Study Director

Investigator Affiliation:

Astrazeneca China R&D

Authority:

China: Food and Drug Administration

Study ID:

NIS-OCN-DUM-2009/1

NCT ID:

NCT01106781

Start Date:

August 2010

Completion Date:

December 2013

Related Keywords:

  • Non-Small Cell Lung Cancer
  • EGFR mutation test
  • NSCLC
  • Non-Interventional Study
  • EGFR mutation status
  • Adenocarcinoma
  • Adenocarcinoma, Mucinous
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location